GlassScriptPhysician profile
Asif Iqbal
NPI 1174907737
$342.95
in general payments reported to CMS, 2019-2025
7 companies · $73.94 in 2025
The $73.94 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.45 · 2021: $42.71 · 2022: $56.01 · 2024: $146 · 2025: $73.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $145.84 | 2024 | Onyx Frontier |
| Janssen Pharmaceuticals, INC | $85.13 | 2021-2022 | |
| Stemline Therapeutics INC. | $37.97 | 2025 | Orserdu |
| Allergan, INC. | $24.45 | 2019 | |
| Janssen Biotech, INC. | $18.13 | 2025 | Rybrevant |
| Merck Sharp & Dohme LLC | $17.84 | 2025 | Keytruda |
| Novartis Pharmaceuticals Corporation | $13.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.